Sanofi Stock Rebounds 3.5% in One Week
The pharmaceutical company extends its October rebound in a rising CAC 40. The stock is moving away from its early-month lows, but remains below a long-term benchmark.
A 30-day high now acting as support, with 4.79% gain over the 20-day moving average
The price of Sanofi stands at €76.09 in mid-session trading, up 0.77% from the previous day. It has just surpassed its 30-day high at €75.51, which now serves as support. This movement extends a recovery of 3.43% over the week, following the lowest point since 2018 touched in early October, discussed in our coverage of the stock.
The price is above the 20-day moving average (with a 4.79% gap), so short-term momentum has remained bullish. The RSI at 62 remains in an intermediate zone. The 200-day moving average at €76.63 remains uncaptured: the price is 0.70% below it.
A Paris market oriented upward and a key date set for October 30
The CAC 40 gains 0.89% at midday and the SBF 120 0.88%, while Sanofi ranks in the middle of the index, well behind Renault (+6.26%) leading the index. Over one month, the stock has gained 5.68%, but it remains down 12.79% over one year.
The interest rate environment has not changed: the 10-year OAT stands at 4.94% according to the latest Bank of France reading on October 28. In the short term, the group will publish its third-quarter results on October 30.
The latest financial report, covering the first half of 2026 published on July 30, 2026, set guidance for expected revenue of nearly €48 billion for the following fiscal year.
